Calithera Biosciences, Inc. (CALA)
Calithera Biosciences, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in South San Francisco, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $487. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of -1.25 implies it has historically moved less than the broad market.
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Calithera Biosciences, Inc. is most often compared with the following Healthcare names: